Taiwan’s Centers for Disease Control logged 95,916 influenza-like illness visits during epidemiological week 43, a 7 percent drop from the prior week, even as the agency flagged rising respiratory syncytial virus activity in hospital surveillance networks.
The mixed picture, published as part of the health ministry’s Sunday update, suggests flu may be easing after an early autumn surge while RSV fills pediatric wards—timing that matters for school attendance and outpatient staffing.
Lab trends
Virology teams reported that influenza positivity rates declined modestly among sent specimens, consistent with the outpatient dip. RSV detections, however, ticked up in northern medical centers, prompting reminders that two respiratory seasons can overlap when temperatures swing sharply, as they did across Taiwan last week.
Epidemiologists cautioned against declaring victory. Week 43 still sits above historical averages for November, and holiday travel in the weeks ahead could reintroduce strains from colder climates. Whole-genome sequencing continues on severe cases to watch for vaccine mismatch.
Vaccination context
Public flu and COVID-19 shots surpassed 4.7 million cumulative doses by early November, buoyed by health-coin incentives and expanded eligibility for adults aged 50 to 64 without chronic conditions. Coverage remains uneven: roughly 40 percent of seniors in some counties have yet to receive the seasonal jab, according to county health departments cited in local media.
Scientists said high uptake among students helped dampen classroom clusters, but RSV lacks an equally broad public program for older children. Hospitals are prioritizing monoclonal antibody prophylaxis for high-risk infants while urging parents to keep febrile toddlers home.
Why week 43 matters
Surveillance week 43 captures the transition from mid-autumn to pre-winter weather. Taiwan’s electricity loads have not yet peaked, yet clinics already report night-time crowding. If ILI visits rise again while RSV grows, emergency departments could face a double burden without the cross-immunity seen when one virus dominates.
Researchers plan to publish a composite chart tying outpatient volume to wastewater RSV signals later this month. For now, the science desk read is straightforward: flu slowed slightly in week 43, another respiratory pathogen did not. Planning for both curves remains the prudent public-health response.
Hospital operations
Emergency physicians in Taipei reported shorter waiting times after midweek, when ILI visits peaked, but pediatric departments still allocate overflow beds for RSV bronchiolitis. Nurse unions asked hospitals to stagger shift bonuses for weekends when both viruses circulate.
Wastewater pilots in Taoyuan and Tainan will add RSV quantification this month, giving epidemiologists earlier warning than clinic counts alone. Scientists said correlating wastewater spikes with retail vaccination traffic could refine where mobile clinics deploy.
International travelers remain a wild card. Hong Kong and Japan logged rising respiratory admissions, and CDC teams monitor arriving flights for severe cases without reimposing border tests. Policy emphasis stays on vaccination and antiviral stockpiles rather than travel curbs.
Academic partners upload sequence data to GISAID within days of sampling, supporting global comparisons if a novel variant emerges. Week 43 sequences showed no abrupt antigenic shift, easing fears of a vaccine mismatch this month.